Marco DiBonaventura

13PUBLICATIONS
29CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical infection agents (incl. prions)Gene and molecular therapyAllergyMajor global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Mar 19, 2026
Real-World Treatment Patterns of Elranatamab in Patients with Multiple Myeloma in Japan: The EVEREST Study.

Satoshi Yoshihara, Aster Meche, Patrick Hlavacek

|Jun 10, 2025
An Updated Indirect Comparison of Elranatamab Versus a Real-World External Control Arm in Triple-Class Refractory Multiple Myeloma.

Luciano J Costa, Thomas W LeBlanc, Hans Tesch

|Feb 29, 2024
Impact of elranatamab on quality of life: Patient-reported outcomes from MagnetisMM-3.

Mohamad Mohty, Nizar J Bahlis, Ajay K Nooka

|Feb 28, 2024
Elranatamab efficacy in MagnetisMM-3 compared with real-world control arms in triple-class refractory multiple myeloma.

Luciano J Costa, Thomas W LeBlanc, Hans Tesch

|Aug 25, 2023
Interpreting the Relationship Among Itch, Sleep, and Work Productivity in Patients with Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of JADE MONO-2.

Gil Yosipovitch, Melinda J Gooderham, Sonja Ständer

|Jul 13, 2022
Real-World Effectiveness of Newly Initiated Systemic Therapy for Atopic Dermatitis in the United States: A Claims Database Analysis.

Jashin J Wu, Marie-Hélène Lafeuille, Bruno Emond

Pageof 3

Frequent Collaborators

2 joint publications

Daniela E Myers

2 joint publications

Joseph C Cappelleri

1 joint publications

J I Silverberg

1 joint publications

J P Thyssen